The refractory gout market is growing because of the rising prevalence of gout brought on by aging populations and changes in ...

In addition to adherence challenges, discontinuation of prescription treatment due to adverse effects is also a challenge in the medical management of gout.

XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

Gout tophi totally disappeared and renal function remained stable. The patient continues to receive rasburicase treatment. P Richette is a Rheumatologist and T Bardin is a Professor of ...

If you have gout, a doctor can help you develop a treatment plan to manage your flares. This may include changes to your diet and medications that can help prevent gout attacks. This is not a ...

XORTX Therapeutics (XRTX) announces the launch of a new late stage program to treat gout. The new drug development program – XRx-026 – will ...

The current target of gout treatment is to reduce levels down to 6 mg/dL or less. SEL-212 is based on a uricase enzyme (pegadricase) that breaks down uric acid in the blood combined with an immune ...

METHODS Prospective, parallel, open study of 86 consecutive male patients with primary chronic gout. Forty nine patients (26 normal excretors and 23 under excretors) were given allopurinol 300 mg/day ...

Here’s the truth: there is no cure for gout, although there are many ways to treat it and prevent flare-ups. Oddly enough, ...

Gout is a painful form of inflammatory arthritis ... and heart and kidney diseases that can increase the chances it will occur. The goal of treatment is to reduce levels of uric acid in the ...

One of the treatment objectives in current guidelines is ‘cure’. However, audits show that only a minority of patients with gout receive adequate advice and treatment. Suboptimal care and outcomes ...